BRAF inhibitors promote erythropoiesis and hematopoiesis via paradoxical MAPK activation
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 14 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 14 samples: 7 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signalingSignal transduction and targeted therapy · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE261119_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1085310 and SRA study SRP493997. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 14 samples.
How we read this: 7 replicated groups read from 14 sample titles; they account for 14 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8135457 CD34 cells, CTRL_ATACseq, D6, rep1 CD34 cells, CTRL_ATACse…
- GSM8135458 CD34 cells, CTRL_ATACseq, D6, rep2 CD34 cells, CTRL_ATACse…
- GSM8135459 CD34 cells, GDC_ATACseq, D6, rep1 CD34 cells, GDC_ATACseq…
- GSM8135460 CD34 cells, GDC_ATACseq, D6, rep2 CD34 cells, GDC_ATACseq…
- GSM8135461 CD34 cells, V600E_ATACseq, D6, rep1 CD34 cells, V600E_ATACs…
- GSM8135462 CD34 cells, V600E_ATACseq, D6, rep2 CD34 cells, V600E_ATACs…
- GSM8135463 CD34 cells, WT_ATACseq, D6, rep1 CD34 cells, WT_ATACseq,…
- GSM8135464 CD34 cells, WT_ATACseq, D6, rep2 CD34 cells, WT_ATACseq,…
- GSM8135465 CD34 cells, CTRL_RNAseq, D6, rep1 CD34 cells, CTRL_RNAseq…
- GSM8135466 CD34 cells, CTRL_RNAseq, D6, rep2 CD34 cells, CTRL_RNAseq…
- GSM8135467 CD34 cells, GDC_RNAseq, D6, rep1 CD34 cells, GDC_RNAseq,…
- GSM8135468 CD34 cells, GDC_RNAseq, D6, rep2 CD34 cells, GDC_RNAseq,…
- GSM8135469 CD34 cells, V600E_RNAseq, D6, rep1 CD34 cells, V600E_RNAse…
- GSM8135470 CD34 cells, V600E_RNAseq, D6, rep2 CD34 cells, V600E_RNAse…
- GSE308064 PAD4⁺ Neutrophils Promote Hepatic Stellate Cell Activation and Accelerate MASH Fibrosis Progression via NETs-DNA/TAOK1/MAPK Pathways 6 samples shares mapk, activation, promote
- GSE280266 Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory circuits During Response to MAPK Inhibition in BRAF-mutant colorectal cancer. 48 samples shares braf, mapk
- GSE280280 Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory circuits During Response to MAPK Inhibition in BRAF-mutant colorectal cancer 36 samples shares braf, mapk
- GSE287599 Multi-omics Dissection of MAPK-driven Senescence Unveils Therapeutic Vulnerabilities in KIAA1549::BRAF-fusion Pediatric Low-Grade Glioma Models 15 samples shares braf, mapk
- GSE248208 Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition 99 samples shares mapk, activation
- GSE298507 Inhibition of BCL2 family proteins overcomes acquired resistance to standard of care BRAF and MEK inhibitors in a subset of BRAFV600E-mutant melanomas 58 samples shares braf, inhibitors
- GSE301645 Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia 24 samples shares mapk, inhibitors
- GSE262667 SRSF7-mediated Alternative Splicing of USO1 Promotes Hepatocellular Carcinoma by Activating the MAPK/ERK1-ELK1 Pathway 19 samples shares mapk, promote
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.